^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

BCL2 positive

i
Other names: BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Entrez ID:
Phase 3
Fondazione Italiana Linfomi - ETS
Recruiting
Last update posted :
02/23/2024
Initiation :
12/14/2023
Primary completion :
04/01/2031
Completion :
04/01/2031
BCL2
|
BCL2 positive
|
Gazyva (obinutuzumab)
Phase 1b
Peter MacCallum Cancer Centre, Australia
Recruiting
Last update posted :
05/22/2023
Initiation :
09/25/2019
Primary completion :
06/01/2024
Completion :
12/01/2025
HER-2 • ER • BCL2
|
ER positive • HER-2 negative • BCL2 positive
|
Venclexta (venetoclax) • Ibrance (palbociclib) • letrozole
Phase N/A
Ruijin Hospital
Not yet recruiting
Last update posted :
05/18/2023
Initiation :
06/01/2023
Primary completion :
11/30/2024
Completion :
11/30/2025
BCL2
|
BCL2 positive
|
Venclexta (venetoclax) • cytarabine • etoposide IV • carmustine • melphalan
Phase 1/2
University of Chicago
Active, not recruiting
Last update posted :
04/28/2023
Initiation :
07/29/2014
Primary completion :
07/29/2023
Completion :
07/29/2023
MYC • BCL2 • CD20 • BCL6 • IRF4 • MME
|
BCL2 positive
|
Rituxan (rituximab) • lenalidomide • doxorubicin hydrochloride • cyclophosphamide • etoposide IV • vincristine • prednisone • melphalan • cyclophosphamide intravenous
Phase 2
Fondazione Italiana Linfomi ONLUS
Completed
Last update posted :
06/21/2022
Initiation :
10/01/2014
Primary completion :
04/01/2018
Completion :
04/07/2022
BCL2
|
BCL2 positive
|
Arzerra (ofatumumab)
Phase 1
Celgene
Completed
Last update posted :
08/28/2020
Initiation :
04/29/2015
Primary completion :
01/29/2020
Completion :
01/29/2020
MYC • BCL2
|
BCL2 positive
|
Rituxan (rituximab) • doxorubicin hydrochloride • cyclophosphamide • vincristine • prednisone • Onureg (azacitidine oral)
Phase 2
Arbeitsgemeinschaft medikamentoese Tumortherapie
Completed
Last update posted :
01/09/2018
Initiation :
01/01/2004
Primary completion :
07/01/2009
Completion :
07/01/2010
BCL2
|
BCL2 positive • BCL2 rearrangement
|
Rituxan (rituximab) • mitoxantrone